Global Digital Pathology Market Size By Product (Scanners, Software, Communication Systems), By Application (Disease Diagnosis, Teleconsultation), By End-User (Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories), By Geographic Scope And Forecast

Digital Pathology Market Size And Forecast

Digital Pathology Market size was valued at USD 628.54 Million in 2021 and is projected to reach USD 1719.31 Million by 2030, growing at a CAGR of 13.64% from 2022 to 2030.

The increasing demand for personalized medicine along with high growth opportunities in emerging countries will create various revenue streams for the Digital Pathology Market and it will grow at a rapid pace. The Global Digital Pathology Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Digital Pathology Market Definition

Imagine thispathology with a high-tech twist! Digital pathology is like the tech-savvy cousin of traditional pathology. It's all about using computers and digital slides to analyze tissue samples. Just like you can view slides under a microscope, digital pathology uses virtual microscopy on a computer screen. This may sound like a minor change, but it's actually revolutionizing how pathology labs work. With digital pathology, pathologists can easily manage and share digital slides of tissue samples. No more fumbling with glass slides! They can zoom in, adjust brightness, and even use special computer tools to analyze the tissue. And get thisdigital pathology has even led to automated analysis of tissue markers. These "smart" tools can identify and count different biomarkers in the tissue, helping pathologists with diagnosis and treatment recommendations.

Primary diagnosis, diagnosing consultation, intraoperative diagnosis, medical student and resident training, manual and semi-quantitative immunocytochemistry (IHC) review, clinical research, diagnostic decision support, peer assessment, and tumor boards are all instances of healthcare applications of digital pathology. Some of the Life Science applications involve high-throughput scanning of glass slides, quantitative analysis of entire slide images, real-time web-based consultations with expert pathologists, and safe data retention. With special support for education, tissue-based research, drug development, and the profession of human pathology all around the world, digital pathology is rapidly gaining traction as a proven and significant technology.

Global Digital Pathology Market Overview

The way doctors use digital tools to study medical images, like biopsies, is changing how labs work. This shift is fueling the growth of the digital pathology market, especially since the number of people getting cancer is also on the rise. The World Health Organization (WHO) says that cancer kills about one out of every six people in the world. Lung, prostate, colon, stomach, and liver cancers are the most common in men. For women, the top cancers are breast, colon, lung, cervical, and thyroid. As cancer cases increase around the globe, the burden it places on individuals, families, governments, and healthcare systems is getting heavier. That's why digital pathology, which can speed up and streamline diagnoses, is becoming more important.

Digital Pathology is a game-changer in treating a wide range of diseases. It's like a super-tool that helps doctors see deeper and diagnose better. That's why it's such a big deal in medical research. Plus, it's becoming super useful in developing new drugs and helping doctors choose the right treatments for their patients. And with healthcare costs going up in many countries, especially in the developing world, Digital Pathology is helping us keep healthcare affordable. For example, Taiwan spends a whopping 6.6% of its total money on healthcare. That's a lot! And other Asian countries like Japan, South Korea, and Singapore aren't far behind. What's more, companies that make Digital Pathology tools are working hard to make them even better. So, it's no wonder that the Digital Pathology market is growing like crazy.

However, some difficulties are limiting the Global Digital Pathology Market’s growth. The high cost of digital pathology systems may restrict the Global Digital Pathology Market’s growth. Furthermore, the scarcity of trained professionals will pose multiple difficulties to the market’s growth over the forecast period. Nonetheless, the introduction of low-cost scanners is anticipated to provide lucrative opportunities for the expansion of the Digital Pathology Market

Global Digital Pathology MarketSegmentation Analysis

The Global Digital Pathology Market is Segmented on the basis of Product, Application, End-User, and Geography.

Digital Pathology Market, By Product

• Scanners
• Software
• Communication Systems
• Storage Systems

Based on Product, the market is bifurcated into Scanners, Software, Communication Systems, and Storage Systems. The scanners segment dominated the Global Digital Pathology Market owing to the increasing adoption of digital pathology solutions across the globe. Moreover, the high incidence and prevalence of cancer and other chronic diseases are expected to escalate the growth of the Digital Pathology Market.

Digital Pathology Market, By Application

• Disease Diagnosis
• Teleconsultation
• Drug Discovery
• Training and Education

Based on Application, the market is bifurcated into Disease Diagnosis, Teleconsultation, Drug Discovery, and Training and Education. The drug discovery segment dominated the Global Digital Pathology Market owing to the rising need for numerous preclinical and clinical studies performed during the drug discovery and development process.

Digital Pathology Market, By End-User

• Pharmaceutical & Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic & Research Institutes

Based on End-User, the market is bifurcated into Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes. The pharmaceutical and biotechnological companies contributed majorly to the growth of the Global Digital Pathology Market. The dominance of the said end-user segment is credited to the rising use of digital pathology for drug discovery studies.

Digital Pathology Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

On the basis of Geography, the Global Digital Pathology Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North America region holds the largest share of the Digital Pathology Market. The region’s market growth is expected to be fuelled by the early adoption of Digital Pathology and the emergence of several vendors that offer Digital Pathology. Increasing demand for quality diagnostics and the rising prevalence of cancer are the factors that are further propelling the growth of the North America Digital Pathology Market.

Key Players

The “Global Digital Pathology Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are 3DHISTECH, Hamamatsu Photonics, Leica Biosystems, Koninklijke Philips, Apollo Enterprise Imaging, XIFIN, Ventana Medical Systems, Visiopharm, Corista, and Huron Digital Pathology. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations, and Agreements

• In May 2021, Leica Biosystems which is a leading medical devices company announced a collaboration with the European Society for Digital and Integrative Pathology (ESDIP). The aim of this collaboration is to support the pathology Labs in order to develop the laboratories in accordance with the new digital pathology devices.

Mergers and Acquisitions

• In July 2020, PathXL which is a leading digital pathology image analysis company that was acquired by Koninklijke Philips N.V. in 2016 has now been sold to cirdan which is a leading medical technology company. The PathXL has a wide range of digital pathology software applications that are mainly used for research and education purposes. Also, it is leading to the growth in the pathology market which includes bio-pharma.
• In March 2021, F. Hoffmann-La Roche AG, commonly known as Roche which is a Swiss healthcare company signed a definitive merger agreement with GenMark Diagnostics Inc. which is a leading molecular diagnostics company. This merger will expand the company’s portfolio and distribution channel for consumers in Europe.
• In October 2020, Pathognomics Limited which is a leading provider of digital pathology and clinical diagnostic laboratory services has been acquired by Cyted Ltd which is a leading developer and provider of AL-based technology and digital diagnostic infrastructure. This acquisition will provide the company accredited laboratory environment and digital pathology technology.

Product Launches and Product Expansions

• In January 2021, F. Hoffmann-La Roche AG, commonly known as Roche launched uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis algorithms for precision patient diagnosis in breast cancer. The image analysis algorithms use artificial intelligence to support pathologists in making fast and accurate patient diagnoses of breast cancer.
• In August 2020, Leica Biosystems, a global leader in pathology workflow solutions, launched Aperio GT 450 DX digital pathology scanner in the European market. Aperio GT 450 DX delivers the technology that provides immediate benefits in primary diagnoses such as improved throughput, reduced turnaround times, and high-quality images.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

Introducing the Market Analysis Masterpiece Our market analysis is a comprehensive guide that digs deep into the market landscape, providing you withMarket SegmentationWe break down the market into segments based on both financial and non-financial factors, giving you a clear understanding of the various market players. Segment Value We provide the estimated market value (in billions of USD) for each segment and sub-segment, helping you identify the most lucrative areas. Growth ForecastWe predict which region and segment will experience the most significant growth, so you can focus on the most promising areas. Regional Analysis We explore the consumption patterns, market trends, and key factors influencing the market in different regions worldwide. Competitive LandscapeWe rank the major players in the market and provide insights into their latest launches, partnerships, and acquisitions, giving you a competitive edge. Company Profiles We offer in-depth profiles of the top companies, including company overviews, product comparisons, and SWOT analyses. Market OutlookWe forecast the future of the industry based on emerging trends, growth drivers, and challenges, helping you stay ahead of the curve. Porter's Five Forces Analysis We evaluate the market forces to identify opportunities and potential threats. Value Chain AnalysisWe provide a clear understanding of the market's value-creation process. Market Dynamics We uncover the growth opportunities and key factors shaping the market's future. Post-Sales Support For six months, our analysts will be available to answer any questions you may have.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.